1 The DKO strain was generated as a model for focal retinal degeneration after report of senescent Ccl2 single knockout mice developing key characteristics of human age-related macular degeneration (AMD) and the discovery of an association between CX3CR1 single nucleotide polymorphisms and AMD.
tumor necrosis factor-inducible gene 6 recombinant protein (TSG-6) arrest of focal retinal lesions. 1 The DKO strain was generated as a model for focal retinal degeneration after report of senescent Ccl2 single knockout mice developing key characteristics of human age-related macular degeneration (AMD) and the discovery of an association between CX3CR1 single nucleotide polymorphisms and AMD. [2] [3] [4] [5] The Ccl2 and Cx3cr1 deficient DKO strain exhibits AMD-like features such as retinal pigmented epithelium (RPE) alteration, photoreceptor atrophy, immune activation and A2E elevation and thus has been suggested as an appropriate model for human AMD. 6, 7 As compared with independently-generated Ccl2 and Cx3cr1 single knockout strains, DKO shows earlier onset, higher penetrance and more lesions (Fig. 1) . Therefore, this strain has served as a valuable tool for screening therapies for human AMD.
The recent finding of the accidently introduced crumbs-like 1 (Crb1) mutation and Crb1 rd8-associated retinal dystrophy in the C57BL/6N background however, has challenged DKO as an AMD mouse model. 8, 9 CRB1 is thought to be involved in maintaining the integrity of the external limiting membrane and mutations in CRB1 result in genetic retinal disorders such as retinitis pigmentosa and Leber congenital amaurosis in humans. 10 The Crb1 rd8 mutation results in irregular retinal lesions in the inferior nasal quadrant of the fundus and thus is suggested to have potential implications for all ocular vision research models on C57BL/6N background, including DKO (hereon referred to as DKO rd8).
While differences in mouse and human physiology limit the formation of drusen proper, 13 infrequent appearance of drusen-like lesions in DKO rd8, which has not been reported in Crb1 rd8 mice, demonstrate distinct retinal pathology between the two strains.
14 In general, C57BL/6N mice seem to have much less severe retinal phenotypes with exception of the foci of mild retinal dystrophy (Fig.  2B ) compared with the Crb1 rd8 mice (Bo Chang, personal communication).
In addition to photoreceptor degeneration, RPE alteration is a cardinal feature of human AMD. 15, 16 One of the prominent histopathologies in DKO rd8 is abnormal RPE cells, which display hypopigmentation, depigmentation, vacuolation and findings suggest the primary pathology of Crb1 rd8 mice to be developmental defects in Müller cells and photoreceptor inner and outer segment shortening, resulting in the secondary pathology of retinal dysplasia and degeneration of focal photoreceptors. Thus, Crb1 rd8 is a model of retinal dystrophy resulting from malformed Müller cell apical villi.
12
DKO rd8 mice also show photoreceptor pathology (Fig. 2D) . 6 However, in addition to photoreceptor dystrophic lesions, RPE degeneration appears to be a featured pathological event in DKO rd8. Whereas retinal folds and pseudorosettes are frequently seen in Crb1 rd8 mice (Fig. 2C) , these retinal lesions are seldom found in DKO rd8 (Fig. 2D) .
Although it is critical to create retinal degeneration on rd8 background, the DKO rd8 mice develop not only retinal dystrophy (a few, mild Crb1 rd8 lesions in C57B/6N mouse) but also additional focal retinal degenerative lesions. While the retinal lesions in these mouse strains may appear clinically similar (Fig. 1) This finding indicates a "founder effect" mutation in C57BL/6N, suggesting that transgenic and knockout models created on the C57BL/6N background carry the Crb1 mutation and thus may present rd8-associated pathology. 8 Crb1 rd8 -associated pathology is characterized by fundus lesions in the inferior nasal quadrant corresponding to abnormal Müller cells, retinal folds and pseudorosettes between the inner and outer nuclear layers. Within these retinal dystrophic lesions there is shortening and disarray of focal photoreceptor inner and outer segments (Fig. 2C) . 11 It is thought that the rd8 mutation results in truncation of the transmembrane and cytoplasmic domain of Crb1, disrupting the adhesion of adherens junction proteins to the external limiting membrane (ELM, comprised of zonula adherens that link photoreceptors and Müller cells) and affecting the development of photoreceptor inner and outer segments. 11 In the Crb1 rd8 mouse, loss of adherens junctions and the Müller cell apical processes underlying the junctions of the ELM is observed. Crb1 is largely absent or diffuse in Müller cell apical processes, which are aberrantly prominent in the inner nuclear layer. Preservation of normal inner and outer segment length is seen in areas adjacent to the region of degeneration.
11 These -/-has retinal lesions that are greater in number than Crb1 rd8 , but markedly less than DKo rd8.
RPE apoptosis and neurodegeneration. [17] [18] [19] Compared with age-matched C57BL/6N mice, a 3-to 4-fold increase of ocular A2E is seen in DKO rd8. 6, 14 Contrastingly, Crb1 rd8 and C57BL/6J mice do not show elevated A2E levels (Fig. 3) . The generation of A2E is considered to be the consequence of burst oxidative stress that is not related in mechanism to the function of Crb1, a component of the molecular scaffold. 20 
Immunopathology of DKO rd8
The DKO rd8 model expresses a spectrum of immunological features of AMD. Increased deposition of complement factors, altered secretion of chemokines and cytokines, and the accumulation of activated microglia and macrophages in retinal lesions have been linked to human AMD and can correspondingly be demonstrated in the DKO rd8. Expression of CD46, a regulatory protein of complement proteins C3 and C4, suggests the presence of activated complement. 6 Elevated expression of C3d is seen in
Elevated Lipofuscin Biochemical Marker A2E in DKO rd8
Accumulation of the lipofuscinfluorophore A2E, a well-known biochemical marker of human AMD, is seen in DKO rd8. A2E accumulation is associated with retinal aging and is known to activate the complement system as well as induce atrophy. 6, 14 Contrastingly, RPE histology is relatively preserved in Crb1 rd8 mice and in patients with Leber congenital amaurosis (LCA), a disease associated with Crb1 mutation, even in the advanced stages. 10 These observations suggest that Crb1 rd8 -associated and DKO rd8-associated pathologies may not operate through identical mechanisms. rd8 and DKo rd8 strains at 2 mo. DKo rd8 shows an a2e increase of more than 3-fold compared with the other three strains. *p < 0.05 in DKo rd8 compared with age-matched C57BL/6J, C57BL/6n and Crb1 rd8 .
EVER abstract, 2012, Ulrich F. Luhmann, EVER abstract 2012). Crb1 rd8 mice primarily show retinal lesions at the ELM whereas DKO rd8 show Cx3cr1 results in more pronounced phenotype of rd8-associated degeneration, a finding that was maintained in the Ccl2 and Cx3cr1 double knockout (HepingXu, RPE and photoreceptors of DKO rd8 and the recruitment of microglia and macrophages in subretinal and retinal lesions is also observed. 21 Consistent with AMD patients, DKO rd8 mice demonstrate increased expression of antiretinal autoantibodies. 21 Moreover, the DKO rd8 strain shows greater macrophage infiltration and complement factor deposition than Crb1 rd8 or C57BL/6N (Fig. 4A and B) , suggesting that immune dysfunction or activation of innate immunity, which is documented in human AMD, seen in DKO rd8 cannot reasonably be accounted for by the rd8 mutation alone. These results suggest that the immunopathology seen in DKO rd8 should not be thought of as solely secondary immune response to rd8-associated retinal dystrophy, and indicate that DKO rd8 recapitulation of AMD-like immunopathology is not the same as rd8-mediated immunopathology.
Ccl2 -/-/Cx3cr1
-/-and Crb1 rd8
Interaction
As evidenced by differences in photoreceptor atrophy and RPE degeneration, DKO and Crb1 rd8 pathology are distinct.
Ccl2
-/-/Cx3cr1 -/-deficiency and the rd8 mutation thus produce two different types of lesions, which, despite arising from distinct mutations, nonetheless interact and modify each other at some level. material that were transported along with the "knocked out" gene onto C57BL/6N background, having created potential sites of genetic variability. 24 Genetic confounders arising from traditional knockout technology using 129 and C57BL/6 may have substantial impact on phenotype, as the two mouse strains have significant genetic and physiological differences and 129 is known to have a multitude of its own mutations. 24 Currently, there is no clear model for recapitulating the full clinical features of AMD. 7 It must be taken into consideration that mice lack macula and thus, no murine model can ever fully recapitulate human AMD. Oxidative damage models dependent on phototoxicity or high fat diet alone or in combination do not show all characteristic RPE changes, increased levels of A2E or complement deposition. 25, 26 Induced choroidal neovascularization using matrigel, laser photocoagulation or elevated VEGF expression fail to model mechanisms behind the presentation of disease and thus do not result in increases of A2E or complement deposition. [27] [28] [29] [30] Immunization with carboxyethylpyrrole (CEP)-adducted protein in mice shows RPE alteration and complement deposition, yet retinal lesions independent of macrophage accumulation are observed and choroidal neovascularization does not develop in this model. 31, 32 Nonetheless, a growing body of evidence implicating AMD as an immunological lesions in retinal inner and outer segment layer, suggesting that Ccl2 and Cx3cr1 double deficiencies could play a role in the high penetrance of rapid photoreceptor and RPE degeneration seen in DKO rd8. Intervention studies conducted on DKO rd8 show reduction or stabilization of these deeper retinal lesions but may have little or no effect on rd8 lesions in the ELM. 13, 22, 23 Study of an independentlygenerated
strain by Luhmann et al. discredited DKO rd8 as a model for AMD, citing the primary role of rd8 in the observed early onset retinal degeneration. 9 While the rd8 mutation may contribute critically to photoreceptor degeneration, the RPE pathology, immune dysfunction, and A2E accumulation as manifested in DKO rd8 still require further explanation. Thus, interaction between Ccl2, Cx3cr1 and rd8 originated from C57BL/6N is possible and further investigation is needed to elucidate the exact mechanisms and how they fit in to a model for AMD.
DKO rd8 as a Model for AMD
When discussing the implications of the rd8 mutation in the DKO rd8 mouse model, consideration must be given to the influence of the genetic background of any engineered mouse model for disease. The generation of knockout mice using 129 and C57BL/6N strains exposed the model to the possibility of "passenger" genes, residual regions of 129-derived genetic disease necessitates that any mouse model feature immunopathological mechanisms. 33, 34 While the genetic roles and interactions of Ccl2, Cx3cr1 and rd8 are not fully elucidated, the recapitulation of certain features of human AMD can be demonstrated in DKO rd8. Within known AMD mouse models, DKO rd8 is a model to date that demonstrates focal RPE alteration, photoreceptor atrophy, enhanced A2E accumulation, and dysregulation of the immune system. 6, 14, 34 While the identification of rd8 and rd8-associated retinal phenotype does impact the power of DKO rd8 as a model for AMD, the use of the model as selfcontrol by treating one eye and using the contralateral eye as the control allows for appropriate experimental interventional studies. Thus, DKO rd8 may still serve as a suitable and relevant model for compound screening on focal retinal degenerative diseases including AMD. In intervention studies on DKO rd8, treatment is shown to alleviate photoreceptor and RPE lesions that can be attributed to Ccl2 and Cx3cr1 double deficiencies while leaving rd8 lesions unaffected. Such is the case with the report by Tuo (2012) that TSG-6 arrested lesions in the retina.
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